Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Monoclonal Gammopathy of Undetermined Significance (MGUS)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07598422
What this trial is testing

Assess the Effectiveness and Safety of Canakinumab in Clinical Use in Patients With Schnitzler's Syndrome

Who this might be right for
Schnitzler Syndrome
Novartis Pharmaceuticals 10
Not applicableStudy completedNCT03951220
What this trial is testing

The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss

Who this might be right for
MyelomaMonoclonal Gammopathy of Undetermined Significance (MGUS)Smouldering Myeloma
Oxford University Hospitals NHS Trust 67
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00003082
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Arizona 27
Testing effectiveness (Phase 2)WithdrawnNCT01571726
What this trial is testing

Imaging Studies and the Development of Multiple Myeloma

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01390350
What this trial is testing

Ilaris® Effects in Schnitzler Syndrome (ILESCH)

Who this might be right for
Schnitzler Syndrome
Charite University, Berlin, Germany 20
Not applicableNot Yet RecruitingNCT07305662
What this trial is testing

Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGUS/SMM: A Pilot Study

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Myeloma
Seoul National University Bundang Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT00899353
What this trial is testing

Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple MyelomaChronic Lymphocytic Leukemia
Marshall University 16
Testing effectiveness (Phase 2)WithdrawnNCT04213274
What this trial is testing

Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome

Who this might be right for
Schnitzler SyndromeUrticarial Vasculitis With Monoclonal Immunoglobulin M Component, Schnitzler (Disorder)
R-Pharm Overseas, Inc.
Not applicableNot Yet RecruitingNCT06750965
What this trial is testing

Multi-center Screening for Serum M Protein

Who this might be right for
Monoclonal GammopathyMultiple MyelomaM-protein
Zhujiang Hospital 10,000
Not applicableActive Not RecruitingNCT03327597
What this trial is testing

Iceland Screens, Treats or Prevents Multiple Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance
University of Iceland 80,761
Early research (Phase 1)Study completedNCT04439006
What this trial is testing

Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization

Who this might be right for
Aplastic AnemiaHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm+4 more
Jennifer Woyach 10
Testing effectiveness (Phase 2)WithdrawnNCT06046287
What this trial is testing

Daratumumab for Polyneuropathy Associated With MGUS

Who this might be right for
Peripheral NeuropathyMonoclonal Gammopathy of Undetermined Significance
Georgetown University
Testing effectiveness (Phase 2)Ended earlyNCT00942422
What this trial is testing

Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell NeoplasmPrecancerous Condition
Barbara Ann Karmanos Cancer Institute 8
Not applicableLooking for participantsNCT02269592
What this trial is testing

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Myelodysplastic SyndromesHematological Malignancies+5 more
Dana-Farber Cancer Institute 10,000
Early research (Phase 1)Ended earlyNCT00004058
What this trial is testing

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Medicine and Dentistry of New Jersey
Early research (Phase 1)Study completedNCT03820817
What this trial is testing

Rifaximin in Patients With Monoclonal Gammopathy

Who this might be right for
IgA Monoclonal GammopathyIgG Monoclonal GammopathyIgM Monoclonal Gammopathy+6 more
Emory University 50
Not applicableUnknownNCT02933021
What this trial is testing

Unravel MGUS (Monoclonal Gammopathy of Unknown Significance)

Who this might be right for
Monoclonal Gammopathy of Unknown Significance
RxCelerate Ltd 664
Large-scale testing (Phase 3)Study completedNCT00661999
What this trial is testing

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Mayo Clinic 502
Large-scale testing (Phase 3)Study completedNCT00666211
What this trial is testing

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Vanderbilt-Ingram Cancer Center 98
Next Page